SCHEMBL27633360

SCHEMBL27633360

CC(=O)OCCn1cncc1O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 2/20 0.46
ALDH1A1 P00352 4/20 0.42
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
SLC18A3 Q16572 1/20 0.35
RXFP1 Q9HBX9 3/20 0.34
TP53 P04637 1/20 0.34
MAPK1 P28482 1/20 0.34
ACACB O00763 1/20 0.33
CYP11B1 P15538 2/20 0.33
CYP11B2 P19099 2/20 0.33
KDM4E B2RXH2 2/20 0.33
HPGD P15428 1/20 0.33
ADRA1A P35348 1/20 0.33
HSD17B10 Q99714 1/20 0.33
PGR P06401 1/20 0.32
CHRM2 P08172 1/20 0.32
CHRM4 P08173 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27762022 0.81 ADORA2B (0.44) ADORA2BALDH1A1MEN1KMT2ACYP1A2
SCHEMBL27811680 0.81 ADORA2B (0.44) ADORA2BALDH1A1MEN1KMT2ACYP1A2
SCHEMBL20547480 0.79 MEN1 (0.40) ADORA2BALDH1A1MEN1KMT2ACYP1A2
SCHEMBL11615550 0.77 GLA (0.47) ADORA2BALDH1A1MEN1KMT2ACYP1A2
SCHEMBL25642259 0.69 ADORA2B (0.48) ADORA2BALDH1A1MEN1KMT2ASLC18A3
SCHEMBL28735251 0.67 ADORA2B (0.49) ADORA2BALDH1A1MEN1KMT2ASLC18A3
SCHEMBL27782413 0.67 CYP11B1 (0.40) ADORA2BCYP11B1CYP11B2
SCHEMBL13587959 0.67 ALDH1A1 (0.50) ADORA2BALDH1A1KMT2AKDM4ESMN1; SMN2
SCHEMBL502049 0.66 SMN1; SMN2 (0.66) MEN1KMT2ASMN1; SMN2TSHRMAPT
SCHEMBL501640 0.66 TBXAS1 (0.54) ALDH1A1MEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100404535-C Organic compounds useful as medicaments for the treatment of aldosterone-mediated conditions NOVARTIS AG (CH) 2008-07-23 CN disclosed
CN-1688583-A Organic compounds as agents for the treatment of aldosterone mediated conditions NOVARTIS AG (CH) 2005-10-26 CN disclosed